Biogen Inc.

Location

Massachusetts

Founded

1978-02-28

Risk Signals

2647 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Biogen Inc.

Live alerts from global media, monitored by Business Radar

Canadian Solar ($CSIQ) Subsidiary Secures 100 MW Solar Deal with Texas Consortium | Canadian Insider

2025-03-01 (canadianinsider.com)

Canadian Solar ($CSIQ) Subsidiary Secures 100 MW Solar Deal with Texas Consortium | Canadian Insider

The only place for free North American stock rankings incorporating insider commitment. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Home of the Canadian Insider Club which offers alerts and premium research.

Read more
BIOGEN INC. SEC 10-K Report —  News

2025-02-12 (tradingview.com)

BIOGEN INC. SEC 10-K Report — News

Biogen Inc., a leading biopharmaceutical company specializing in neurological and rare disease treatments, has released its 2024 Form 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic initiatives, and the challenges it f…

Read more
Entropy Technologies LP Acquires New Holdings in Biogen Inc. (NASDAQ:BIIB)

2025-02-09 (marketbeat.com)

Entropy Technologies LP Acquires New Holdings in Biogen Inc. (NASDAQ:BIIB)

Entropy Technologies LP bought a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 34,397 shares of the biotechnology company's stock, valued at approximately $5,260,000.

Read more
Czech National Bank Acquires 1,923 Shares of Biogen Inc. (NASDAQ:BIIB)

2025-01-16 (marketbeat.com)

Czech National Bank Acquires 1,923 Shares of Biogen Inc. (NASDAQ:BIIB)

Czech National Bank boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,595 shares of the biotechnology company's stock after acquiring

Read more
Biogen appoints new Chief Accounting Officer By

2025-01-16 (investing.com)

Biogen appoints new Chief Accounting Officer By

Biogen Inc. (NASDAQ: ), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. The announcement, based on a recent SEC filing, indicates a strategic shift in the company's finance leadership as current Chief Financial Officer Michael McDonnell is set to retire on the same date.

Read more
GAMMA Investing LLC Decreases Position in Biogen Inc. (NASDAQ:BIIB) -

2025-01-13 (defenseworld.net)

GAMMA Investing LLC Decreases Position in Biogen Inc. (NASDAQ:BIIB) -

Read GAMMA Investing LLC Decreases Position in Biogen Inc. (NASDAQ:BIIB) at Defense World

Read more
Franklin Resources Inc. Sells 13,723 Shares of Biogen Inc. (NASDAQ:BIIB)

2024-12-17 (marketbeat.com)

Franklin Resources Inc. Sells 13,723 Shares of Biogen Inc. (NASDAQ:BIIB)

Franklin Resources Inc. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 374,747 shares of the biotechnology company's stock after selling 13,723 shares during the period. Frankli

Read more
Quantinno Capital Management LP Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

2024-12-15 (marketbeat.com)

Quantinno Capital Management LP Lowers Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Quantinno Capital Management LP lowered its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 62.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,069 shares of the biotechnology company's stock after selling 5,172

Read more
Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

2024-12-13 (marketbeat.com)

Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)

Inspire Trust Co. N.A. grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 58.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,900 shares of the biotechnology company's stock after buying an additional 4,0

Read more

Never miss a headline about Biogen Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages